Literature DB >> 581080

Lipid composition of sputum from patients with asthma and patients with cystic fibrosis.

S Sahu, W S Lynn.   

Abstract

Lipids from the sputum of patients with asthma and with cystic fibrosis were isolated and characterized. In both cases, lipids constituted approximately 30% of the dry material. Phosphatidlycholine was the most abundant lipid, Significant amounts of phosphatidylethanolamine and phosphatidylglycerol were present. Hexosyl ceramides, sphingomyelin, phosphatidylinositol, lysophosphatidylcholine, and lysophosphatidylethanolamine were present as minor lipid components. Apperciable quantities of neutral lipids were present, of which triglycerides and cholesterol were the main constituents. Phosphatidylcholine, sphingomyelin, and phosphatidylgycerol were highly saturated. Large amounts of phosphatidylcholine containing mostly palmitic acid, particularly in the asthmatic sputum, suggest htat this highly saturated. Large amounts of phosphatidylcholine containing mostly palmitic acid, particularly in the asthmatic sputum, suggests that this highly saturated phospholipid is synthesized in the upper airways for reasons other than its beneficial surface-active properties in the alveoli.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 581080     DOI: 10.1007/bf00917319

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  26 in total

1.  Determination of cholesterol using o-phthalaldehyde.

Authors:  L L Rudel; M D Morris
Journal:  J Lipid Res       Date:  1973-05       Impact factor: 5.922

2.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

3.  Composition of surface-active material isolated from beef lung.

Authors:  M H KLAUS; J A CLEMENTS; R J HAVEL
Journal:  Proc Natl Acad Sci U S A       Date:  1961-11-15       Impact factor: 11.205

4.  The identification of phosphatidylglycerol in the rat, rabbit, monkey and human lung.

Authors:  S A Rooney; P M Canavan; E K Motoyama
Journal:  Biochim Biophys Acta       Date:  1974-07-26

5.  Variations among vertebrates of lung phospholipid case composition.

Authors:  C F Baxter; G Rouser; G Simon
Journal:  Lipids       Date:  1969-05       Impact factor: 1.880

6.  Lipid composition of human bronchial mucus.

Authors:  R W Lewis
Journal:  Lipids       Date:  1971-11       Impact factor: 1.880

7.  Pulmonary alveolar proteinosis. Nature and origin of alveolar lipid.

Authors:  J Ramirez; W R Harlan
Journal:  Am J Med       Date:  1968-10       Impact factor: 4.965

8.  Pulmonary surfactant and evolution of the lungs.

Authors:  J A Clements; J Nellenbogen; H J Trahan
Journal:  Science       Date:  1970-08-07       Impact factor: 47.728

9.  Lipids found in pulmonary lavage of patients with alveolar proteinosis and in rabbit lung lamellar organelles.

Authors:  S Sahu; R P DiAugustine; W S Lynn
Journal:  Am Rev Respir Dis       Date:  1976-07

10.  Lipid composition of airway secretions from patients with asthma and patients with cystic fibrosis.

Authors:  S Sahu; W S Lynn
Journal:  Am Rev Respir Dis       Date:  1977-02
View more
  4 in total

1.  Clinical Relevance of Type II Fatty Acid Synthesis Bypass in Staphylococcus aureus.

Authors:  Karine Gloux; Mélanie Guillemet; Charles Soler; Claire Morvan; David Halpern; Christine Pourcel; Hoang Vu Thien; Gilles Lamberet; Alexandra Gruss
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

Review 2.  The Use of Artificial Sputum Media to Enhance Investigation and Subsequent Treatment of Cystic Fibrosis Bacterial Infections.

Authors:  Aditi Aiyer; Jim Manos
Journal:  Microorganisms       Date:  2022-06-22

Review 3.  Role of Sphingolipids in the Pathobiology of Lung Inflammation.

Authors:  Riccardo Ghidoni; Anna Caretti; Paola Signorelli
Journal:  Mediators Inflamm       Date:  2015-12-03       Impact factor: 4.711

4.  Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers.

Authors:  Joost Brandsma; Victoria M Goss; Xian Yang; Per S Bakke; Massimo Caruso; Pascal Chanez; Sven-Erik Dahlén; Stephen J Fowler; Ildiko Horvath; Norbert Krug; Paolo Montuschi; Marek Sanak; Thomas Sandström; Dominick E Shaw; Kian Fan Chung; Florian Singer; Louise J Fleming; Ana R Sousa; Ioannis Pandis; Aruna T Bansal; Peter J Sterk; Ratko Djukanović; Anthony D Postle
Journal:  Metabolomics       Date:  2018-09-17       Impact factor: 4.290

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.